“Mead Johnson Nutrition said it tested the same batch of powdered baby formula as public health authorities, confirming the safety results.”
Meanwhile, other retailers pulled product off shelves. Will a 3rd party, or FDA, confirm findings and if so when?
This video is from September 2010 and explains how infant positioners pose a risk to small children and newborns. While once popular and well received both the FDA & CPSC combined to warn parents about how infants were at risk from use of these positioners in cribs. Please repost. These are still potentially in use by unknowing parents.
(Source: http)
#TOPAMAX is a prescription medication used for migraine headaches and epilepsy. It is also known as #TOPIRAMATE. The image above is available from the Food & Drug Adminisration and relates to a #recall of #TOPAMAX or #TOPIRAMATE from April 2011. Here is a link to information on this particular recall from the FDA. At the time, the voluntarily #recalled lots were being pulled from the market due to uncharacteristic odor per the manufacturer J&J. Notably, J&J’s McNeil unit, as well as J&J have had a series of #recalls over the past year and half that have lead to Congressional Hearing and an internal investigation.
Gabriel F. Zambrano, P.A. is investigating cases of #clef #palate, #cleft #lip and #fetal #injuries from the use of #TOPAMAX or #TOPIRAMATE by pregnant women and girls. During 2011, the FDA and manufacturer, announced an increased risk of #oral #cleft injuries from these pills when taken during pregnancy. This marked increase in risk has prompted lawsuits and investigations into what was known by the manufacturer, and when, and how, if at all communication of this information was delayed to the general public. Gabriel F. Zambrano, P.A., is the sponsor of this blog and commentary, and has posted other related posts on this subject available here.
The image above depicts a #cleft #lip and #palate. This image is from a Mayo Clinic website that provides information on the formation and treatment of such a cleft injury.
The FDA announced, on March 4, 2011, that a popular prescription medication - #TOPAMAX (#TOPIRMATE), which is used to treat migraine headaches, and epilepsy, has been linked to an increased risk in pregnant women for fetal injury and formation of a cleft lip or cleft palate. Risks associated with cleft deformation include problems, eating, talking and/or ear infections. Additional information from the FDA, including Q & A on “Risk of Oral Clefts in Infants Born to Mothers Taking Topamax (Topiramate)” can be found at FDA.gov
Gabriel F. Zambrano, P.A, the sponsor of this blog and post is investigating cases of fetal harm involving the use of TOPAMAX (TOPIRMATE) and oral cleft injuries, cleft palates and cleft lips.
J&J’s #McNeil #recall of Children’s Liquid Medicines was initiated over a year ago. Some products are still not available. This image can be found http://www.tylenol.com/page2.jhtml?id=tylenol/news/subp_prd_peds_availability.inc
J&J, McNeil and related companies have #recalled a number of products in the past 18 months. When the popular children’s products will return to store shelves remains to be seen.
Gabriel F Zambrano, http://www.recallattorneys.co, is actively investigating cases involving McNeils recalled Children’s Liquid Medicine. Potential adverse events include “Stevens Johnson Syndrome” or “SJS”, related complications and resulting disabilities.
SSRI’s (selective serotonin reuptake inhibitors) are reportedly being linked to an increased risk of infant injuries or fetal harm that includes heart defects. A Danish study noted a 60% increase in risk for delivery of a child with a heart defect when compared to a woman that did not take an SSRI while pregnant. Skull and abdominal abnormalities have also been associated with the use of SSRI’s.
The cardiac injuries are literally “holes in the heart” and are typically either Atrial Septal Defects (ASD) or Ventricular Septal Defects (VSD). Basically, these injuries involve an abnorma opening in the dividing walls between either the upper filling chambers of the heart (ASD) or in the wall between the left/right ventricles (VSD).
An increased risk of Persistent Pulmonary Hypertension (PPH) with SSRI’s has also been noted in medical literature. PPH causes breathing problems and respiratory distress as a result of a newborn failing to transition from fetal to newborn circulation. Additional injuries include the following Omphalocele malformation of the abdomen resulting in a newborn’s intestine failing to form within the abdominal cavity. Craniosynostosis, a deformity of the skull involving a premature closing of the skull bone plates and resulting misaligned asymmetrical shape of the head.
At this time, http://www.recallattorneys.com is investigating cases involving the trademarked drugs: ZOLOFT, LEXAPRO, CELEXA, PROZAC and PAXIL. We are also investigating other products identified at http://www.facebook.com/recallattorneysrecalllawyers and often post bulletins or information on this Facebook Page. We also post information on TWITTER via @recallattorneys or http://www.twitter.com/recallattorneys Need additional information ? Feel free to contact us.
How many recalls can one company, or a related group, become associated with in a 1 or 2 year period of time? Look at J&J, McNeil, DePuy and their beleagured product line. Info posted at http://www.facebook.com/recallattorneysrecalllawyers
This particular link highlights the proverbial “Tip of the Iceberg” as of May 2010. Fast forward to this year and you appreciate the complicated landscape of recalls, as well as litigation coming with regard to TOPAMAX and infant, or fetal harm, to children while they were still in the womb! Wonder how many more problems in 2011.
This link explores how TOPAMAX (TOPIRMATE) is FDA approved as an anti-seizure medication for epilepsy and to prevent migraines. However, as of March 2011, physicians and others are being warned of the risk of fetal harm, that includes, but may not be limited to cleft lip or cleft palate. How high is the risk ? 16x higher among women taking TOPAMAX or a generic equivalent. Do you know someone that gave birth to a newborn w/with a cleft lip or cleft palate? Prior to March 2011, this was not really out there for everyone to consider or appreciate. If the manufacturer knew, and for how long before, if at all, prior to the FDA announcing these risks remains to be determined. Wonder how this call came to pass ? Need info?
